Research work · 1961

Fibrinolytic Agents

Kenneth Μ. Moser

JAMA

Abstract

To the Editor:— Differences of opinion, theory, and method are to be expected in any complex new field of medical investigation. While these differences are well recognized by the few physicians working on a specific problem, they are not apparent to physicians engaged primarily in other pursuits. Therefore, when the data and conclusions of one group in a highly specialized field are published, such information may be generally interpreted as fact rather than as representative of one point of view. These considerations have prompted this belated comment on an article by Fletcher and asso associates which appeared on Feb. 27, 1960 inThe Journal; this report seems seems to have promoted confusion among physicians regarding the status of fibrinolytic agents. The methods used by Fletcher and associates and their interpretation of data led them to express the opinion that one fibrinolytic agent of the activatorplasmin type (Actase) might not prove effective as a clot dissolvant in man. This

DOI: 10.1001/jama.1961.03040040068021